CD4 and neoplasm: Th2-polarized CD4+ T cells produce cytokines (e.g. IL-4, IL-13) that can dampen Th1 responses and impair the function of cytotoxic T lymphocytes, thereby weakening the immune system’s ability to attack tumor cells (48, 49).